Venous Thromboembolism

Cardiovascular·MeSH: Venous Thromboembolism

6 drugs in development·3 companies·12 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
bevyxxa	PORTOLA PHARMACEUTICALS INC (PTLA)

Phase 3(3)

Drug	Company
abelacimab	Dianthus Therapeutics, Inc. /DE/ (DNTH)
acetylsalicylic acid	REGENERON PHARMACEUTICALS, INC. (REGN)
dalteparin	Dianthus Therapeutics, Inc. /DE/ (DNTH)

Phase 2(2)

Drug	Company
regn7508	REGENERON PHARMACEUTICALS, INC. (REGN)
regn9933	REGENERON PHARMACEUTICALS, INC. (REGN)

BioSniper tracks 6 drugs in development for Venous Thromboembolism across 3 companies.

There are 12 clinical trials targeting Venous Thromboembolism tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.